Limit this search to....

Pioneering Stem Cell/Gene Therapy Trials
Contributor(s): Bertolotti, Roger (Author), Ozawa, Keiyo (Author), Kirk Hammond, H. (Author)
ISBN: 9067643947     ISBN-13: 9789067643948
Publisher: CRC Press
OUR PRICE:   $266.00  
Product Type: Hardcover - Other Formats
Published: October 2003
Qty:
Temporarily out of stock - Will ship within 2 to 5 weeks
Annotation: The first unequivocal success for Gene Therapy was reported in April 2000 for X-SCID patients. Pioneering stem cell/gene therapy clinical trials are the focus of this book. Therapy successes such as the X-SCID trial and improved ADA-SCID ones are presented together with pioneering angio/vasculogenic clinical trials mediated either by transient gene therapy or emerging autologous stem cell transplantation. Highlights also include 1) promises of the breakthrough combination of stem cell- and transient gene-therapy, 2) gene therapy trials for neurodegenerative disease on non-human primates where long-term gene therapy might involve brain stem cells, and 3) the first clinical trial with non-invasive monitoring of therapeutic gene expression as a prospective conclusion.
This volume will be of value and interest to researchers in this exciting field.

Additional Information
BISAC Categories:
- Medical | Diseases
- Architecture | Interior Design - General
- Science | Life Sciences - Genetics & Genomics
Dewey: 616.042
LCCN: 2004300806
Series: Progress in Gene Therapy
Physical Information: 0.78" H x 6.36" W x 9.66" (1.70 lbs) 330 pages
 
Descriptions, Reviews, Etc.
Publisher Description:

The first unequivocal success for Gene Therapy was reported in April 2000 for X-SCID patients. Pioneering stem cell/gene therapy clinical trials are the focus of this book. Therapy successes such as the X-SCID trial and improved ADA-SCID ones are presented together with pioneering angio/vasculogenic clinical trials mediated either by transient gene therapy or emerging autologous stem cell transplantation. Highlights also include 1) promises of the breakthrough combination of stem cell- and transient gene-therapy, 2) gene therapy trials for neurodegenerative disease on non-human primates where long-term gene therapy might involve brain stem cells, and 3) the first clinical trial with non-invasive monitoring of therapeutic gene expression as a prospective conclusion.
This volume will be of value and interest to researchers in this exciting field.